
### [MONDO:0004814](http://purl.obolibrary.org/obo/MONDO_0004814)
**Label:** vascular skin disease

**Subclasses:** [MONDO:0009925](http://purl.obolibrary.org/obo/MONDO_0009925) (pseudoxanthoma elasticum), [MONDO:0018975](http://purl.obolibrary.org/obo/MONDO_0018975) (neurofibromatosis), [MONDO:0008075](http://purl.obolibrary.org/obo/MONDO_0008075) (neurofibromatosis type 3), [MONDO:0013357](http://purl.obolibrary.org/obo/MONDO_0013357) (chromosome 17q11.2 deletion syndrome, 1.4Mb), [MONDO:0008077](http://purl.obolibrary.org/obo/MONDO_0008077) (neurofibromatosis, type 1), 

**Corr. equiv. classes:** [OMIM:162200](http://purl.obolibrary.org/obo/OMIM_162200), [OMIM:162210](http://purl.obolibrary.org/obo/OMIM_162210), [OMIM:162260](http://purl.obolibrary.org/obo/OMIM_162260), [Orphanet:363700](http://www.orpha.net/ORDO/Orphanet_363700), [OMIM:162270](http://purl.obolibrary.org/obo/OMIM_162270), [OMIM:177850](http://purl.obolibrary.org/obo/OMIM_177850), [OMIM:162091](http://purl.obolibrary.org/obo/OMIM_162091), [Orphanet:139474](http://www.orpha.net/ORDO/Orphanet_139474), [OMIM:615670](http://purl.obolibrary.org/obo/OMIM_615670), [Orphanet:93921](http://www.orpha.net/ORDO/Orphanet_93921), [OMIM:613675](http://purl.obolibrary.org/obo/OMIM_613675), [OMIM:264800](http://purl.obolibrary.org/obo/OMIM_264800), [Orphanet:636](http://www.orpha.net/ORDO/Orphanet_636), [Orphanet:97685](http://www.orpha.net/ORDO/Orphanet_97685), [Orphanet:637](http://www.orpha.net/ORDO/Orphanet_637), [Orphanet:758](http://www.orpha.net/ORDO/Orphanet_758), [OMIM:101000](http://purl.obolibrary.org/obo/OMIM_101000), 

**Class expressions from DL-Learner:**

- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 67.36%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 67.36%
- [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 67.36%
- [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 67.36%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) and [HP:0100835](http://purl.obolibrary.org/obo/HP_0100835) (Benign neoplasm of the central nervous system) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0002858](http://purl.obolibrary.org/obo/HP_0002858) (Meningioma) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 64.71%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0100835](http://purl.obolibrary.org/obo/HP_0100835) (Benign neoplasm of the central nervous system) 64.71%
- [HP:0000957](http://purl.obolibrary.org/obo/HP_0000957) (Cafe-au-lait spot) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0002858](http://purl.obolibrary.org/obo/HP_0002858) (Meningioma) 64.71%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 64.68%
- [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 64.68%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) 64.68%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 64.68%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 64.68%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) 64.68%
- [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0001067](http://purl.obolibrary.org/obo/HP_0001067) (Neurofibromas) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 64.68%


